Minneapolis, MN, United States of America

Eric P Flores


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Eric P. Flores in Brain Cancer Treatment

Introduction

Eric P. Flores, an inventor based in Minneapolis, MN, has made significant strides in the field of medical research, particularly in the treatment of primary brain cancer. With a patent to his name, Flores has emerged as a key figure in the development of novel therapies that utilize antisense oligonucleotides to inhibit the growth of cancerous cells.

Latest Patents

Flores holds a patent for a groundbreaking invention titled "Antisense oligonucleotides and methods for treating central nervous," which provides compositions and methodologies aimed at treating primary brain cancer. The invention focuses on antisense oligonucleotides that target and inhibit the proliferation of cancer cells. Specifically, these oligonucleotides are designed to be complementary to and hybridize with the mRNA encoding c-myb, a gene associated with cell proliferation in brain tumors. The methods described in the patent involve administering a pharmaceutical composition containing these antisense oligonucleotides to patients, thereby effectively inhibiting the growth of primary brain cancer cells. This innovation also includes probes and primers for identifying brain cells with amplified or rearranged c-myb genes.

Career Highlights

Eric P. Flores is affiliated with the University of Minnesota, where he conducts his research and collaborates with esteemed colleagues in the medical field. His work showcases a dedication to advancing cancer treatments, reflecting his commitment to addressing one of the most challenging areas of healthcare.

Collaborations

Throughout his career, Flores has worked alongside notable researchers such as Walter C. Low and Walter A. Hall. These collaborations have likely fostered an environment of innovation and shared knowledge, contributing to the successful development of his patented technologies.

Conclusion

With his innovative approach to treating primary brain cancer through targeted antisense oligonucleotides, Eric P. Flores exemplifies how research and inventions can lead to effective medical therapies. His contributions to the field reinforce the importance of continued research and collaboration in the quest to combat diseases that affect the central nervous system.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…